Purple Biotech to Speak at Oncology Conference
Ticker: PPBT · Form: 6-K · Filed: Apr 1, 2025 · CIK: 1614744
Sentiment: neutral
Topics: conference-participation, oncology, biotech
TL;DR
Purple Biotech speaking at Canaccord oncology virtual conference April 7th.
AI Summary
Purple Biotech Ltd. announced on April 1, 2025, that it will participate in a panel discussion at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 7, 2025. The company, formerly known as Kitov Pharma Ltd., is based in Rehovot, Israel.
Why It Matters
The company's participation in this conference provides visibility and an opportunity to discuss its developments within the oncology sector.
Risk Assessment
Risk Level: low — This filing is a routine announcement of participation in a conference, with no new financial or operational information disclosed.
Key Players & Entities
- Purple Biotech Ltd. (company) — Registrant
- Canaccord Genuity (company) — Conference Host
- Horizons in Oncology Virtual Conference (company) — Event Name
- April 7, 2025 (date) — Conference Date
- April 1, 2025 (date) — Announcement Date
- Kitov Pharma Ltd. (company) — Former Company Name
FAQ
What is the name of the virtual conference Purple Biotech will participate in?
Purple Biotech will participate in the Canaccord Genuity Horizons in Oncology Virtual Conference.
On what date is the panel discussion scheduled?
The panel discussion is scheduled for April 7, 2025.
When did Purple Biotech issue the press release about their participation?
The press release was issued on April 1, 2025.
What was Purple Biotech Ltd. formerly known as?
Purple Biotech Ltd. was formerly known as Kitov Pharma Ltd.
Where is Purple Biotech Ltd. located?
Purple Biotech Ltd. is located at 4 Oppenheimer Street, Science Park, Rehovot, Israel.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 1, 2025 regarding PURPLE BIOTECH LTD. (PPBT).